Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
The FASEB Journal (Impact Factor: 5.48). 09/2003; 17(11):1458-69. DOI: 10.1096/fj.02-1040com
Source: PubMed

ABSTRACT Platelet endothelial cell adhesion molecule-1 (PECAM-1), an immunoglobulin family vascular adhesion molecule, is involved in endothelial cell migration and angiogenesis (1, 2). We found that endothelial cells lacking PECAM-1 exhibit increased single cell motility and extension formation but poor wound healing migration, reminiscent of cells in which Rho activity has been suppressed by overexpressing a GTPase-activating protein (3). The ability of PECAM-1 to restore wound healing migration to PECAM-1-deficient cells was independent of its extracellular domain or signaling via its immunoreceptor tyrosine-based inhibitory motif. PECAM-1-deficient endothelial cells had a selective defect in RhoGTP loading, and inhibition of Rho activity mimicked the PECAM-1-deficient phenotype of increased chemokinetic single cell motility at the expense of coordinated wound healing migration. The wound healing advantage of PECAM-1-positive endothelial cells was not only Rho mediated but pertussis toxin inhibitable, characteristic of migration mediated by heterotrimeric G-protein-linked seven-transmembrane receptor signaling such as signaling in response to the serum sphingolipid sphingosine-1-phosphate (S1P) (4, 5). Indeed, we found that the wound healing defect of PECAM-1 null endothelial cells is minimized in sphingolipid-depleted media; moreover, PECAM-1 null endothelial cells fail to increase their migration in response to S1P. We have also found that PECAM-1 localizes to rafts and that in its absence heterotrimeric G-protein components are differentially recruited to rafts, providing a potential mechanism for PECAM-1-mediated coordination of S1P signaling. PECAM-1 may thus support the effective S1P/RhoGTP signaling required for wound healing endothelial migration by allowing for the spatially directed, coordinated activation of Galpha signaling pathways.

  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: CD44 has been implicated in a diverse array of cell behaviors and in a diverse range of signaling pathway activations under physiological and pathophysiological conditions. We have documented a role for CD44 in mediating vascular barrier integrity via regulation of PECAM-1 (CD31) expression. We now report our findings on the roles of CD44 in modulating proliferation and apoptosis of microvascular endothelial cells via its modulation of CD31 and VE-cadherin expression and the Hippo pathway. In this report we demonstrate persistent increased proliferation and reduced activations of both effector and initiator caspases in high cell density, post-confluent CD44 knockout (KO) and CD31KO cultures. We found that reconstitution with murine CD44 or CD31 restored the proliferative and caspase activation rates to WT levels. Moreover, we have confirmed that CD31 ecto-domain plays a key role in specific caspase cascades as well as cell-adhesion mediated cell growth and found that CD31 deficiency results in a reduction in VE-cadherin expression. Lastly, we have shown that both CD44KO and CD31KO endothelial cells exhibit a reduced VE-cadherin expression correlating with increased survivin expression and YAP nuclear localization, consistent with inactivation of the Hippo pathway, resulting in increased proliferation and decreased apoptosis. These findings support the concept that CD44 mediates several of its effects on endothelia through modulation of adhesion protein expression, which in addition to its known modulation of junctional integrity, matrix metalloproteinase levels and activation, interactions with cortical membrane proteins and selected signaling pathways, plays a key role as a critical regulator of vascular function.
    Journal of Biological Chemistry 01/2014; 289(9). DOI:10.1074/jbc.M113.529313 · 4.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The highly sialylated vascular endothelial surface undergoes changes in sialylation upon adopting the migratory/angiogenic phenotype. We recently established endothelial cell (EC) expression of NEU1 sialidase (Cross, AS et al; J Biol Chem 287:15966-15980, 2012). We asked whether NEU1 might regulate EC capillary-like tube formation on a Matrigel substrate. In human pulmonary microvascular EC (HPMEC)s, prior silencing of NEU1 did not alter tube formation. Infection of HPMECs with increasing MOIs of an adenovirus (Ad) encoding for catalytically-active wild-type (WT) NEU1 dose-dependently impaired tube formation whereas overexpression of either a catalytically-dead NEU1 mutant, NEU1-G68V, or another sialidase, NEU3, did not. NEU1 overexpression also diminished EC adhesion to the Matrigel substrate and restrained EC migration in a wounding assay. In HPMECs, the adhesion molecule, CD31, also known as platelet endothelial cell adhesion molecule (PECAM)-1, was sialylated via α2,6-linkages, as shown by Sambucus nigra agglutinin (SNA) lectin blotting. NEU1 overexpression increased CD31 binding to Arachis hypogaea or peanut agglutinin (PNA) lectin, indicating CD31 desialylation. In the postconfluent state, when CD31 ectodomains are homophilically engaged, NEU1 was recruited to and desialylated CD31. In postconfluent ECs, CD31 was desialylated compared with subconfluent cells, and prior NEU1 silencing completely protected against CD31 desialylation. Prior CD31 silencing and the use of CD31-null ECs each abrogated the NEU1 inhibitory effect on EC tube formation. Sialyltransferase (ST) 6 GAL-I overexpression increased α2,6-linked CD31 sialylation and dose-dependently counter-acted NEU1-mediated inhibition of EC tube formation. These combined data indicate that catalytically-active NEU1 inhibits in vitro angiogenesis through desialylation of its substrate, CD31.
    Journal of Biological Chemistry 02/2014; 289(13). DOI:10.1074/jbc.M114.555888 · 4.60 Impact Factor


Available from